Corcept Therapeutics Inc. is a pharmaceutical company focused on the research, development, and commercialization of treatments for severe metabolic, oncologic, and neuropsychiatric disorders within the United States. Their primary commercial product, Korlym (mifepristone) tablets, is an oral medication administered…
SectorHealthcare
IndustryMedical - Pharmaceuticals